Clinical Insights Into Prostate Cancer Trial Data | Axel Merseburger

Clinical insights into prostate cancer trial data | Axel Merseburger

Medicine Matters oncology

Genitourinary cancers: Clinical insights into trial data | Axel Merseburger

Medicine Matters oncology

New Study Results: Prostate Cancer Part 1

Support for continuing enzalutamide after mCRPC progression | Axel Merseburger

Medicine Matters oncology

Expert highlights from ASCO GU 2020 | Axel Merseburger

Medicine Matters oncology

Finding & Choosing Clinical Trials for #ProstateCancer | #MarkScholzMD #AlexScholz #PCRI

Prostate Cancer Research Institute

Discussing with Prof. Axel Merseburger about the primary results from the SAUL study

European Association of Urology

Expert highlights: Genitourinary cancers at ASCO 2020 | Axel Merseburger

Medicine Matters oncology

Axel Merseburger - ECC 2015, Vienna - Part 1: Relapse after ADT in Patients with Prostate Cancer

Touch Medical Media

Men's Health, BPH, & #ProstateCancer Q&A With Mark Moyad, MD, MPH & Mark Scholz, MD | #PCRI

Prostate Cancer Research Institute

Axel Merseburger, ESMO 2019 - Advances in metastatic hormone-sensitive prostate cancer

Touch Medical Media

EAU15: Merseburger and Meitland about Differing Perspectives on Anti-Androgen Therapy

European Association of Urology

Demystifying Clinical Trials in Prostate Cancer

University of California Television (UCTV)

All About Clinical Trials for Advanced Prostate Cancer (Royal) | Prostate Cancer Staging Guide

Prostate Cancer Research Institute

ASCO 2020 prostate cancer highlights

Understanding Prostate Cancer: Symptoms, Diagnosis, and Clinical Trial Options

PROMIS trial - what it looked at and the results

Prostate Cancer UK

Prostate Cancer Clinical Trial: ESCAPE Trial

Doctor Grew Explains Cancer

An Interview with Prof. Axel Merseburger at EAU 2014

EMJ

TITAN Trial | Investigating the addition of apalutamide to androgen deprivation therapy

Prostate Cancer Foundation of Australia